Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Pharmaceutical Preparations · Malvern, PA · filing with the SEC since 2010
Filings
216 filings since 2017 beside 92 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Sep 11, 2026.
Filings a yearinsider forms included
2042402152514635
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Oct 30, 2026.Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Mar 25, 2026.SEC letters: 6 in the last 36 months, the newest Sep 30, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Nov 4, 2026
8-K items 2.02, 7.01, 8.01
Results released; Investor disclosure (Regulation FD); Other event · Current report
Nov 4, 2026
8-K items 5.03, 5.07, 9.01
Charter, bylaw or fiscal-year change; Shareholder vote · Current report
Nov 3, 2026
Oct 30, 2026
8-K items 3.01, 7.01, 9.01
Listing warning from its exchange; Investor disclosure (Regulation FD) · Current report
Oct 29, 2026
May 20, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Apr 10, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Apr 9, 2026
Oct 28, 2025
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Oct 26, 2025
Oct 14, 2025
8-K items 1.01, 7.01, 8.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD); Other event · Current report
Oct 10, 2025
40 of 216 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.